about
Dysadherin: a new player in cancer progressionCutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effectsGenetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.Induction of epithelial mesenchimal transition and vasculogenesis in the lenses of Dbl oncogene transgenic mice.CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarizationThe inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.CCL2 blockade augments cancer immunotherapy.The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma.Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Hypoxia potentiates glioma-mediated immunosuppressionRgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cellsAn antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancerMutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypesTumors induce complex DNA damage in distant proliferative tissues in vivoLong-distance inflammatory and genotoxic impact of cancer in vivo.A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer.Macrophages in multiple myeloma: emerging concepts and therapeutic implications.Evidence for the importance of personalized molecular profiling in pancreatic cancer.CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression.Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs.Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population.Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group.Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.Identification of novel markers for the diagnosis of malignant pleural mesothelioma.Lack of TNF-α-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophagesInflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transitionSystemic DNA damage related to cancerGlioma cancer stem cells induce immunosuppressive macrophages/microglia.Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cellsAssociation between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies.Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastasesAdrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth.The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumorsModification of MCF-10A cells with pioglitazone and serum-rich growth medium increases soluble factors in the conditioned medium, likely reducing BT-474 cell growth.Renaming cytokines: MCP-1, major chemokine in pancreatitisPotent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors
P2860
Q24671729-6068C041-DE7C-457F-A19A-439ED1BA205DQ28116529-2C3C1A62-1232-4FE5-ADF8-E7004C1DF2D0Q28235478-7A2C103B-8686-409E-9C64-A6B947E4F6A2Q30855755-5F19ECC0-B990-4FC6-8A40-1BB577E38DD8Q30873811-230C5C1E-27E6-401E-A009-2153694CAE97Q33553562-42841144-D6A3-49DC-9022-2AABDBB7C881Q33587770-6664EFC9-C3B6-4857-93F6-62E8959F7ED0Q33651427-717FA871-C508-41AB-A0BC-1FAE6377914BQ33759124-54084468-11DB-4C10-8861-CBB42E693BDCQ33786788-206A66F6-09C8-4175-B851-2CE2D4899C96Q33809268-7518F83F-B177-4E65-A0A0-1FA7FC2D99BEQ33873408-8EBFD30F-7B96-4BD1-861E-DF004441AF93Q33889144-94DEE3F1-BDD6-4D77-A492-3229A10EE012Q33900352-633789B4-E4BA-42D1-91ED-C8A5D0C29336Q34085831-AE393AD4-9357-4E0A-A5BE-70B11EC84622Q34087806-E5F6FE2D-D8DD-48F9-874D-136476972B42Q34241433-90C0DB66-F03D-4684-86DE-8971095A5324Q34241484-923F3244-B287-434E-984A-98BF75C35689Q34302308-3C35A8B7-C329-4990-AD5A-3F7661247AB0Q34329242-53EAED45-52EA-418D-84CE-07103EF3581EQ34387784-A9F73549-388A-4631-A6DA-DCF85B40D2D1Q34406206-02166359-2921-4507-AC23-384D42C7E04CQ34528303-74AB42E6-7337-4AC2-B8F2-AE1DE4CBBBEFQ34561082-C7CA8279-E1BF-40C8-8885-BDDE938D3618Q34626551-5F4FF757-8DF5-478A-91AD-D0C7C9932C6FQ34706701-EBDA94B0-1781-4517-87A9-ECCC6A35FF3DQ34749424-752C48A0-5FA0-4ECF-8553-B9A320F1F0CEQ34760760-EDAB32F9-733C-4529-A0E7-8C7E71FB493FQ34838946-29E1E94B-0B13-4322-A095-E92CFACB4FE0Q34984217-9B1B7AC7-6C96-4703-8512-BA89950EF927Q34988152-CC1722BA-2F81-445E-96F1-D9940C2FD0D7Q34992518-7A1919EE-E413-46DA-9216-C52E3AF121C7Q35011812-DD30E231-0174-4320-9779-247A95BCA39AQ35075456-38C7EF60-BCF2-4BB4-8731-4E1CA2910908Q35549911-8E454A61-5C8A-4045-8527-DA41C058E104Q35551991-D05F7368-202C-4F8F-983C-0CEAB3365D42Q35865361-107B2A53-E064-4868-9917-BC4A6C33D6F2Q36057300-BCF9BEFB-C6A5-4BED-A5BB-C17539691586Q36164454-2FB9A42D-AE32-4135-8AAA-6131D061B0E2Q36305520-E9CFEC13-AB06-4A44-966C-DA4827CEBCDD
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
CCL2 (monocyte chemoattractant protein-1) and cancer.
@ast
CCL2 (monocyte chemoattractant protein-1) and cancer.
@en
type
label
CCL2 (monocyte chemoattractant protein-1) and cancer.
@ast
CCL2 (monocyte chemoattractant protein-1) and cancer.
@en
prefLabel
CCL2 (monocyte chemoattractant protein-1) and cancer.
@ast
CCL2 (monocyte chemoattractant protein-1) and cancer.
@en
P1476
CCL2 (monocyte chemoattractant protein-1) and cancer.
@en
P2093
Barrett J Rollins
Ilaria Conti
P304
P356
10.1016/J.SEMCANCER.2003.10.009
P577
2004-06-01T00:00:00Z